ZA823980B - 5-asa drug delivery system - Google Patents

5-asa drug delivery system

Info

Publication number
ZA823980B
ZA823980B ZA823980A ZA823980A ZA823980B ZA 823980 B ZA823980 B ZA 823980B ZA 823980 A ZA823980 A ZA 823980A ZA 823980 A ZA823980 A ZA 823980A ZA 823980 B ZA823980 B ZA 823980B
Authority
ZA
South Africa
Prior art keywords
delivery system
drug delivery
asa drug
asa
drug
Prior art date
Application number
ZA823980A
Other languages
English (en)
Inventor
Barnett Sylvain Pitzele
Peter Hadley Jones
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of ZA823980B publication Critical patent/ZA823980B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/08Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA823980A 1981-06-08 1982-06-07 5-asa drug delivery system ZA823980B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/271,748 US4374932A (en) 1981-06-08 1981-06-08 5-ASA Drug delivery system

Publications (1)

Publication Number Publication Date
ZA823980B true ZA823980B (en) 1983-07-27

Family

ID=23036907

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA823980A ZA823980B (en) 1981-06-08 1982-06-07 5-asa drug delivery system

Country Status (13)

Country Link
US (1) US4374932A (de)
EP (1) EP0066861B1 (de)
JP (1) JPS57212119A (de)
AU (1) AU8462282A (de)
CA (1) CA1200204A (de)
DE (1) DE3262768D1 (de)
DK (1) DK253782A (de)
ES (1) ES512897A0 (de)
IE (1) IE53518B1 (de)
NO (1) NO153396C (de)
NZ (1) NZ200882A (de)
PT (1) PT75021B (de)
ZA (1) ZA823980B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57500432A (de) * 1980-03-20 1982-03-11
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
SE8405924L (sv) * 1984-11-23 1986-05-24 Pharmacia Ab Nya azoforeningar
CA2122717C (en) * 1991-11-08 2003-07-15 David C. Anderson Hemoglobins as drug delivery agents
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
DE60140491D1 (de) 2000-08-29 2009-12-24 Biocon Ltd Verwendung einer pharmazeutischen Zusammensetzung mit einem Para-Aminophenylessigsäurederivat für die Behandlung von entzündlichen Erkrankungen des Magen-Darmtrakts
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
EP1429728A1 (de) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Zubereitungen mit verzögerter freisetzung
US7737133B2 (en) * 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
US7825106B2 (en) 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
DK1773767T3 (en) 2004-07-07 2016-03-21 Biocon Ltd Synthesis of azo bound in immune regulatory relations
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
FR2986010A1 (fr) * 2012-01-19 2013-07-26 Biomerieux Sa Detection in vitro de microorganismes presentant une activite azoreductase
JP6564369B2 (ja) 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
CN108479727A (zh) * 2018-03-20 2018-09-04 中山大学惠州研究院 一种水杨酸改性的苯乙烯聚合物及其吸附回收工业废水中苯胺类组分的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB408676A (en) * 1931-10-17 1934-04-16 Ig Farbenindustrie Ag The manufacture of symmetrically substituted azobenzene compounds
US2697059A (en) * 1951-01-22 1954-12-14 Edwin L Gustus Hydroxy aromatic carboxylate-resin adsorption composition
US2721827A (en) * 1952-08-29 1955-10-25 Edwin L Gustus Composition containing polyamine resin having adsorbed thereon an anion of para-aminosalicylic acid
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US3143465A (en) * 1961-06-19 1964-08-04 Wallace & Tiernan Inc Pharmaceutical preparations comprising phosphorus containing cation exchange resins having a basic drug adsorbed thereon; and treatment therewith
SE7905051L (sv) * 1979-06-11 1980-12-12 Pharmacia Ab Nya sulfonamider
SE8002322L (sv) * 1980-03-26 1981-09-27 Pharmacia Ab Medel for behandling av inflammatoriska tarmsjukdomar
DE3027013A1 (de) * 1980-07-17 1982-02-18 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln

Also Published As

Publication number Publication date
ES8304539A1 (es) 1983-03-01
EP0066861B1 (de) 1985-03-27
US4374932A (en) 1983-02-22
AU8462282A (en) 1982-12-16
PT75021A (en) 1982-07-01
IE821361L (en) 1982-12-08
JPS57212119A (en) 1982-12-27
DE3262768D1 (de) 1985-05-02
NO821898L (no) 1982-12-09
EP0066861A1 (de) 1982-12-15
NO153396B (no) 1985-12-02
PT75021B (en) 1984-01-04
NZ200882A (en) 1985-08-30
NO153396C (no) 1986-03-12
IE53518B1 (en) 1988-12-07
CA1200204A (en) 1986-02-04
DK253782A (da) 1982-12-09
ES512897A0 (es) 1983-03-01

Similar Documents

Publication Publication Date Title
GB8322007D0 (en) Pharmaceutical delivery system
ZA82306B (en) Sustained release delivery system
GB2140687B (en) Osmotic drug delivery system
GB8519530D0 (en) Drug delivery system
GB2100705B (en) Monitored delivery systems
GB2166051B (en) Colonic therapeutic delivery system
IL68159A0 (en) Closed drug delivery system
GB2185397B (en) Drug delivery system
DE3570594D1 (en) Closed drug delivery system
ZA857355B (en) Novel drug delivery system
GB8630273D0 (en) Pharmaceutical delivery systems
ZA87737B (en) Drug delivery system
DE3369468D1 (en) Osmotic drug delivery system
HK10088A (en) Inhalation pharmaceuticals
GB2105189B (en) Inhalation drugs
ZA823980B (en) 5-asa drug delivery system
GB2107191B (en) Parenteral delivery system
GB2146525B (en) Drug delivery system
GB2040687B (en) Catheter delivery system
PH25638A (en) Microparticle drug delivery system
EP0182502A3 (en) Drug delivery system
JPS57150960A (en) Delivery stand
ZA795549B (en) Microparticle drug delivery system
JPS57125757A (en) Drug dosing member
ZA824075B (en) Pneumatic-tube conveying system